John Griffin's hedge fund firm Blue Ridge Capital has filed a 13G with the SEC and disclosed a position in Platform Specialty Products (PAH). Per the filing, Blue Ridge now owns 7.72% of the company with 8 million shares.
As we detailed previously, Bill Ackman also owns a PAH stake. The company was formed to acquire companies and their first deal was MacDermid, a specialty chemicals manufacturer. Shares of PAH are newly listed on the NYSE.
It's unclear if Blue Ridge owned a stake in Platform Specialty Products before they listed on the NYSE like Ackman did.
You can view other recent portfolio activity from Blue Ridge Capital here.
Tuesday, February 4, 2014
Blue Ridge Capital Discloses Platform Specialty Products Position
blog comments powered by Disqus
